Estimaciones de analistas de Wall Street para Marex Group Limited (MRX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 7 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 7 |
| Calificación media (1-5) | 1.00 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-08-12 | $1.64 | $1.36 | +20.6% |
| 2026-05-06 | $1.48 | $1.38 | +7.2% |
| 2025-11-06 | $0.96 | $0.92 | +4.3% |
| 2025-05-15 | $0.91 | $0.89 | +1.9% |
| 2024-11-07 | $0.76 | $0.68 | +11.8% |
| 2024-08-14 | $1.33 | $0.68 | +95.6% |
| 2023-06-30 | $1.28 | ||
| 2022-12-31 | $0.90 |
Ratios de valoración
| Ratio P/E | 17.54 |
| Precio / Valor contable | 2.79 |
| EV / EBITDA | 2.54 |
| Rentabilidad por dividendo | 0.90% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | $328.3M | $317.9M | $384.5M | $549.2M | $757.5M | $851.7M | $1.18B | $2.35B | $2.89B | $3.63B |
| Coste de Ventas | 0 | 0 | 0 | 0 | 0 | $609.5M | $313.0M | $659.4M | $1.61B | $917.7M |
| Beneficio Bruto | $328.3M | $317.9M | $384.5M | $549.2M | $757.5M | $825.3M | $862.3M | $1.69B | $1.29B | $2.71B |
| I+D | $389000 | $135000 | $60000 | $639000 | $763000 | 0 | 0 | 0 | 0 | 0 |
| Generales y Administrativos | 0 | 0 | 0 | $211.9M | $276.9M | $82.5M | $120.1M | $798.8M | $247.1M | 0 |
| Gastos Operativos | $302.0M | $292.7M | $339.2M | $541.2M | $701.0M | $144.8M | $223.1M | $798.8M | $450.9M | $1.55B |
| Beneficio Operativo | $26.3M | $25.2M | $45.2M | $12.2M | $56.6M | $68.6M | $270.5M | $683.5M | $836.3M | $1.16B |
| EBITDA | $2.9M | $1.6M | $1.4M | $7.6M | $8.5M | $106.6M | $284.3M | $705.4M | $865.8M | $1.21B |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | $26.4M | $165.0M | $470.2M | $538.1M | $760.2M |
| Beneficio Antes de Impuestos | $27.0M | $25.4M | $13.4M | $46.6M | $55.0M | $69.9M | $121.6M | $196.5M | $295.8M | $411.6M |
| Impuestos | $6.5M | $7.9M | $3.3M | $10.2M | $11.2M | $13.4M | $23.4M | $55.2M | $77.8M | $103.7M |
| Beneficio Neto | $20.5M | $17.5M | $10.2M | $36.4M | $43.8M | $56.5M | $91.6M | $128.0M | $218.0M | $308.2M |
| BPA | $0.34 | $0.29 | $0.17 | $0.60 | $0.72 | $0.80 | $1.29 | $1.94 | $2.72 | $4.13 |
| BPA Diluido | $0.34 | $0.29 | $0.17 | $0.60 | $0.72 | $0.80 | $1.36 | $1.82 | $2.72 | $3.87 |
| Acciones en Circulación (Diluidas) | $60.6M | $60.6M | $60.6M | $60.6M | $60.6M | $70.8M | $70.8M | $72.2M | $75.3M | $76.1M |
Precio
| Precio | $72.38 |
| Capitalización | $5.2B |
| Bolsa | NASDAQ |
| País | GB |
Empresas relacionadas: BANR · ECC · FFBC · FIGR · FRME · PWP · SF
Explorar sector: Financial Services · Financial - Capital Markets
Más secciones de MRX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones